Diagnosing Pediatric Acute Onset Neuropsychiatric Syndrome

by Himabindu Venkatakrishnan on  October 23, 2014 at 10:12 AM Child Health News   - G J E 4
Evaluating the abrupt onset of neuropsychiatric symptoms in children has to be based on a consensus statement recommending the evaluation process. A panel of leading clinicians and researchers across various general and specialty pediatric fields developed this consensus statement to evaluate the neuropsychiatric symptoms that suddenly develop, including the abrupt, dramatic onset of obsessive-compulsive disorder (OCD).
Diagnosing Pediatric Acute Onset Neuropsychiatric Syndrome
Diagnosing Pediatric Acute Onset Neuropsychiatric Syndrome

This difficult diagnosis is typically made by pediatricians or other primary care clinicians and child psychiatrists, who will benefit from the guidance provided in the recommendations published in Journal of Child and Adolescent Psychopharmacology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article, part of a forthcoming special issue on PANS/PANDAS, is available free on the Journal of Child and Adolescent Psychopharmacology website until November 22, 2014.

Representing the PANS Collaborative Consortium, Kiki Chang, MD, Stanford University School of Medicine (Stanford, CA) and coauthors describe the goals of the First PANS Consensus Conference, from which the expert panel derived its recommendations: to clarify the diagnostic boundaries of PANS, to develop systematic strategies for evaluation of suspected PANS cases, and to set forth the most urgently needed studies in the field.

Most cases of PANS appear to be triggered by an infection, and most often an upper respiratory infection. In the article "Clinical Evaluation of Youth with Pediatric Acute Onset Neuropsychiatric Syndrome (PANS): Recommendations from the 2013 PANS Consensus Conference," the authors detail the core components of a thorough diagnostic evaluation, including family history, medical history, physical examination, psychiatric and mental status exam, laboratory studies, and an infectious disease evaluation.

"This is a watershed moment in our thinking about PANS," says Harold S. Koplewicz, MD, Editor-in-Chief of the Journal of Child and Adolescent Psychopharmacology and President of the Child Mind Institute in New York. "For too long confusion and a lack of understanding concerning this syndrome have left severely impaired children with few, if any, treatment options. This effort promises an improvement in the quality of care and we are grateful to be able support it and to publish our special issue on the topic."

Source: Eurekalert

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like